Trupanion (NASDAQ:TRUP) CEO Darryl Rawlings sold 3,500 shares of the firm’s stock in a transaction dated Thursday, September 24th. The shares were sold at an average price of $8.17, for a total value of $28,595.00. Following the completion of the transaction, the chief executive officer now directly owns 1,636,095 shares in the company, valued at $13,366,896.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Shares of Trupanion (NASDAQ:TRUP) traded up 0.36% during midday trading on Friday, reaching $8.25. The company had a trading volume of 124,540 shares. Trupanion has a 12 month low of $5.21 and a 12 month high of $8.83. The firm’s 50 day moving average price is $7.73 and its 200-day moving average price is $8.06. The company’s market capitalization is $233.22 million.
Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.17) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.02. The company had revenue of $35.59 million for the quarter, compared to analyst estimates of $35.58 million. The firm’s quarterly revenue was up 26.7% compared to the same quarter last year. Analysts anticipate that Trupanion will post ($0.65) earnings per share for the current fiscal year.
A number of equities analysts recently commented on TRUP shares. Zacks upgraded Trupanion from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. RBC Capital reaffirmed an “outperform” rating and set a $12.00 price target on shares of Trupanion in a report on Friday, September 18th. Finally, Canaccord Genuity reissued a “buy” rating and set a $10.00 target price on shares of Trupanion in a report on Wednesday, June 17th. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. Trupanion presently has a consensus rating of “Buy” and a consensus price target of $9.08.
Trupanion, Inc. is a direct-to-consumer monthly subscription service company engaged in providing a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to medical insurance plan for cats and dogs. The other business segment includes other operations, such as writing of policies for an unaffiliated general agent and policies written under a federal Government program.